Wang et al. proposed that obesity-associated increases in PD-1 expression on CD8+ TILs promoted heightened anti-PD-1 efficacy (25), and this seems plausible in cases where such a positive association occurs. The gene discussed is CD8A; the disease is obesity due to melanocortin 4 receptor deficiency.